The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
Also known as: Triiodothyronine
Also known as: Free T3, FT3, T3 Free
Also known as: T4 Thyroxine Total
Also known as: Free T4, FT4, T4 Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
Also known as: B12, B12 Vitamin, Cobalamin, Cyanocobalamin, Vitamin B12 Cobalamin
Also known as: B6, B6 Vitamin, Pyridoxal, Pyridoxal Phosphate, Pyridoxal Phosphate (PLP), Vitamin B6 Pyridoxal Phosphate
The TH-3. Hashimoto's Disease panel contains 15 tests with 82 biomarkers.
Brief Description: The TH-3 Hashimoto's Disease panel is a comprehensive diagnostic suite designed specifically for the evaluation and management of Hashimoto's thyroiditis, the most common cause of hypothyroidism. This panel integrates a wide array of tests to assess thyroid function, autoimmune activity, metabolic health, and nutritional status, offering a holistic view of the patient's condition in the context of Hashimoto's Disease.
Collection Method: Blood Draw
Specimen Type: Whole Blood, Serum, and Plasma
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Patient must be restricted from alcohol and vitamins for at least 24 hours before a sample collection.
Collection should be done in the morning.
Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
Healthcare providers may order the TH-3 Hashimoto's Disease panel for patients presenting symptoms suggestive of hypothyroidism, such as fatigue, weight gain, cold intolerance, and dry skin, which could indicate Hashimoto's thyroiditis. It is also used for patients with a known diagnosis of Hashimoto's disease to monitor the disease progression, evaluate the effectiveness of thyroid hormone replacement therapy, and assess the impact of the disease on overall health.
The TH-4 Hashimoto's Disease panel extends the comprehensive evaluation provided by the TH-3 panel by including tests for TSH Receptor Binding Antibody and Thyroid Stimulating Immunoglobulin. These additional tests are particularly beneficial for distinguishing between various forms of thyroiditis and for identifying overlapping thyroid conditions, providing a more nuanced understanding of the patient's autoimmune profile and thyroid health. The TH-4 panel is thus an excellent choice for complex cases where a deeper insight into the autoimmune mechanisms and thyroid function is crucial for effective management.
The TH-3 Hashimoto's Disease panel is primarily used to diagnose and manage Hashimoto's thyroiditis and hypothyroidism. It helps in detecting the autoimmune basis of thyroid dysfunction and in identifying related conditions such as anemia, dyslipidemia, vitamin deficiencies, and metabolic disturbances that can accompany Hashimoto's disease.
Healthcare professionals utilize the results of the TH-3 Hashimoto's Disease panel to diagnose Hashimoto's thyroiditis, evaluate the extent of thyroid dysfunction, and monitor the effectiveness of treatment. The comprehensive nature of the panel also allows for the management of associated conditions, ensuring a holistic approach to patient care.
The TH-3 Hashimoto's Disease panel provides an in-depth evaluation of Hashimoto's thyroiditis, offering critical insights into thyroid function, autoimmune status, and the broader health impacts of thyroid dysfunction. By combining thyroid function tests with assessments for autoimmune markers, metabolic health, and nutritional status, this panel enables healthcare providers to develop targeted treatment strategies, addressing the complexities of Hashimoto's disease and enhancing patient care.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.